These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34396159)

  • 21. Major adverse cardiovascular events of vascular endothelial growth factor tyrosine kinase inhibitors among patients with different malignancy: A systemic review and network meta-analysis.
    Chen YC; Chen JH; Hsieh FI
    J Chin Med Assoc; 2024 Jan; 87(1):48-57. PubMed ID: 37991373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension in elderly--an overview.
    Bhattacharyya A; Das P
    J Indian Med Assoc; 1999 Mar; 97(3):96-101. PubMed ID: 10652909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.
    Hashimoto J; Hirayama H; Hanasawa T; Watabe D; Asayama K; Metoki H; Kikuya M; Ohkubo T; Totsune K; Imai Y
    Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axitinib Induces and Aggravates Hypertension Regardless of Prior Treatment With Tyrosine Kinase Inhibitors.
    Kadowaki H; Ishida J; Akazawa H; Yagi H; Saga-Kamo A; Umei M; Matsuoka R; Liu Q; Matsunaga H; Maki H; Sato Y; Kume H; Komuro I
    Circ Rep; 2021 Mar; 3(4):234-240. PubMed ID: 33842729
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
    Chazova IE; Martynyuk TV
    Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension.
    Heran BS; Chen JM; Wang JJ; Wright JM
    Cochrane Database Syst Rev; 2010 Jan; (1):CD008167. PubMed ID: 20091662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective electronic chart review of blood pressure changes in elderly patients treated with amlodipine or an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker.
    Dollar A; Brown C; Putnam D; McLaughlin T; Okamoto L; Arocho R
    Clin Ther; 2002 Jun; 24(6):930-41. PubMed ID: 12117083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.
    Nosadini R; Tonolo G
    J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.
    Guthrie RM
    Postgrad Med; 2011 Nov; 123(6):58-65. PubMed ID: 22104454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension.
    Calhoun DA; White WB
    J Am Soc Hypertens; 2008; 2(6):462-8. PubMed ID: 20409927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium channel blockers shorten the periodicity of ultradian variation in blood pressure in patients with essential hypertension.
    Kawamura H; Mitsubayashi H; Saito T; Kanmatsuse K; Saito N
    Hypertens Res; 1998 Sep; 21(3):179-86. PubMed ID: 9786602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses.
    Kjeldsen SE; Cha G; Villa G; Mancia G;
    J Clin Pharmacol; 2016 Sep; 56(9):1120-9. PubMed ID: 26829251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
    Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effects of calcium channel blockers and renin-angiotensin-aldosterone system inhibitors on changes in the estimated glomerular filtration rate in patients with polycystic kidney disease.
    Mitobe M; Yoshida T; Sugiura H; Shiohira S; Shimada K; Nitta K; Tsuchiya K
    Clin Exp Nephrol; 2010 Dec; 14(6):573-7. PubMed ID: 20700620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective cohort study to characterise the blood pressure response to spironolactone in patients with apparent therapy-resistant hypertension using electronic medical record data.
    Shuey M; Perkins B; Nian H; Yu C; Luther JM; Brown N
    BMJ Open; 2020 May; 10(5):e033100. PubMed ID: 32461291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.